Beta blokatori − poznati i kaoβ-blokatori,beta-adrenergični blokirajući agensi,beta antagonisti,beta-adrenergični antagonisti,beta-adrenoreceptorski antagonisti ilibeta adrenergičniantagonist receptori – klasa sulijekova koji se propisuju za uporavljanjesrčanim aritmija i zaštitu od drugog srčanog napada (infarkt miokarda), nakon prvog napada (sekundarna prevencija).[1] Također se široko koriste za liječenjehipertenzije, iako više nisu prvi izbor za početno liječenje većine pacijenata prema važećim smjernicama (od2016. godine).[2][3]
ICI-118,551: Visoko selektivni β2-adrenergični receptorski antagonist, nije poznat u kliničkoj primjeni, ali se upotrebljava u eksperimentima zbog jake specifičnosti receptora.
Propranolol je jedini predstavnik indiciran za kontrolu tremora, portne hipertenzije i krvarenje jednjaka, a koji se koriste u kombinaciji s α-blokatorima prifeohromocitomu.
^Clément K, Vaisse C, Manning BS, Basdevant A, Guy-Grand B, Ruiz J, Silver KD, Shuldiner AR, Froguel P, Strosberg AD (august 1995). "Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity".The New England Journal of Medicine.333 (6): 352–4.doi:10.1056/NEJM199508103330605.PMID7609752.CS1 održavanje: upotreba parametra authors (link)
^van der Vring JA, Daniëls MC, Holwerda NJ, Withagen PJ, Schelling A, Cleophas TJ, Hendriks MG (juni 1999). "Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN)".Angiology.50 (6): 447–54.doi:10.1177/000331979905000602.PMID10378820.CS1 održavanje: upotreba parametra authors (link)
^abWiysonge CS, Bradley HA, Volmink J, Mayosi BM, Mbewu A, Opie LH (2012). "Beta-blockers for hypertension".The Cochrane Database of Systematic Reviews.11: CD002003.doi:10.1002/14651858.CD002003.pub4.PMID23152211.CS1 održavanje: upotreba parametra authors (link)
^Chen JM, Heran BS, Perez MI, Wright JM (2010). "Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension".The Cochrane Database of Systematic Reviews (1): CD007185.doi:10.1002/14651858.CD007185.pub2.PMID20091622.CS1 održavanje: upotreba parametra authors (link)
^Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GW, Wright JM (2015). "First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension".The Cochrane Database of Systematic Reviews.1: CD008170.doi:10.1002/14651858.CD008170.pub2.PMID25577154.CS1 održavanje: upotreba parametra authors (link)
^Chen N, Zhou M, Yang M, Guo J, Zhu C, Yang J, Wang Y, Yang X, He L (2010). "Calcium channel blockers versus other classes of drugs for hypertension".The Cochrane Database of Systematic Reviews (8): CD003654.doi:10.1002/14651858.CD003654.pub4.PMID20687074.CS1 održavanje: upotreba parametra authors (link)
^Meinertz T, Willems S (2008). "Die Behandlung von Vorhofflimmern im Alltag" [Treatment of atrial fibrillation in every day practice].Der Internist.49 (12): 1437–42.doi:10.1007/s00108-008-2152-6.PMID19020848.CS1 održavanje: upotreba parametra authors (link)
^Shen, Howard (2008).Illustrated Pharmacology Memory Cards: PharMnemonics. Minireview. str. 15.ISBN1-59541-101-1.
^Umehara S, Goyagi T, Nishikawa T, Tobe Y, Masaki Y (2010). "Esmolol and landiolol, selective beta1-adrenoreceptor antagonists, provide neuroprotection against spinal cord ischemia and reperfusion in rats".Anesthesia and Analgesia.21 (3): 1133–7.doi:10.1213/ANE.0b013e3181cdb06b.PMID20103544.CS1 održavanje: upotreba parametra authors (link)
Musicians and beta-blockers by Gerald Klickstein, March 11, 2010 (A blog post that considers "whether beta-blockers are safe, effective, and appropriate for performers to use.")
In Defense of the Beta Blocker by Carl Elliott,The Atlantic, August 20, 2008. (Discusses the use of propranolol by a North Korean pistol shooter in the 2008 Olympics)
